leisure time -WSS

leisure time

author：entertainment 2025-10-01 06:01:50 - browse：88

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Cherokee Nation medical school graduates its first class

WSS

People can get long Covid without testing positive for virus: Study

Vivek Ramaswamy made waves in the debate, much as in biotech

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Listen: Vivek Ramaswamy's star turn & leaky drug data

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Study: Spinal cord stimulation helps patients with paralysis walk again

hotspot

leisure time

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Supreme Court to hear if Covid misinformation is protected speech

Hepatitis C has a cure — but many Americans still lack access to it

How to make over

Medicare proposal to cover medical devices draws a mixed reaction

FDA advisory panel to debate high blood pressure devices

Activists slam private health insurers over coverage restrictions

Health officials lay out plans to cope with respiratory virus season

As demand for Covid shots wanes, Moderna seeks its next success

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

The United States must get value

Fertility clinic egg and embryo storage is a disaster

Supreme Court to hear if Covid misinformation is protected speech

Oak Street deal isn't the answer to health care's woes

Former Pear Therapeutics executives start new VC firm

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

entertainment

Wikipedia

Wikipedia

focus